Paraskevi Karousi
Overview
Explore the profile of Paraskevi Karousi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elmasri R, Rashwan A, Gaber S, Rostom M, Karousi P, Yasser M, et al.
Noncoding RNA Res
. 2024 Mar;
9(2):547-559.
PMID: 38515792
A non-negligible part of our DNA has been proven to be transcribed into non-protein coding RNA and its intricate involvement in several physiological processes has been highly evidenced. The significant...
2.
Abaza T, Abd El-Aziz M, Daniel K, Karousi P, Papatsirou M, Fahmy S, et al.
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003674
Hepatocellular carcinoma (HCC) is a highly fatal malignancy with limited therapeutic options and high recurrence rates. Recently, immunotherapeutic agents such as immune checkpoint inhibitors (ICIs) have emerged as a new...
3.
Karousi P, Samiotaki M, Makridakis M, Zoidakis J, Sideris D, Scorilas A, et al.
Funct Integr Genomics
. 2023 Nov;
23(4):341.
PMID: 37987851
tRNA fragments (tRFs) are small non-coding RNAs generated through specific cleavage of tRNAs and involved in various biological processes. Among the different types of tRFs, the 3'-tRFs have attracted scientific...
4.
Kontos C, Hadjichambi D, Papatsirou M, Karousi P, Christodoulou S, Sideris D, et al.
Noncoding RNA
. 2023 Oct;
9(5).
PMID: 37888203
CircRNAs have become a novel scientific research hotspot, and an increasing number of studies have shed light on their involvement in malignant progression. Prompted by the apparent scientific gap in...
5.
Karousi P, Kontos C, Papakotsi P, Kostakis I, Skaltsounis A, Scorilas A
Funct Integr Genomics
. 2023 Sep;
23(4):299.
PMID: 37707691
Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by poor prognosis and limited treatment options. Oleuropein and oleocanthal are bioactive chemicals found in extra-virgin olive oil; they...
6.
Kontos C, Karousi P, Artemaki P, Abdelgawad A, Dimitriadou A, Machairas N, et al.
FEBS Open Bio
. 2023 Jul;
13(10):1953-1966.
PMID: 37424436
Circular RNAs (circRNAs), a novel RNA type generated by back-splicing, are key regulators of gene expression, with deregulated expression and established involvement in leukemia. The products of BCL2 and its...
7.
Sklirou A, Gianniou D, Karousi P, Cheimonidi C, Papachristopoulou G, Kontos C, et al.
Int J Mol Sci
. 2022 Sep;
23(17).
PMID: 36077156
Small heat shock proteins (sHSPs) are ubiquitous ATP-independent chaperones that contribute to the maintenance of proteome integrity and functionality. Recent evidence suggests that sHSPs are ubiquitously expressed in numerous types...
8.
Karousi P, Papanota A, Artemaki P, Liacos C, Patseas D, Mavrianou-Koutsoukou N, et al.
Biomedicines
. 2021 Dec;
9(12).
PMID: 34944627
Multiple myeloma (MM) is a hematologic malignancy arising from the clonal proliferation of malignant plasma cells. tRNA-derived RNA fragments (tRFs) constitute a class of small non-coding RNAs, deriving from specific...
9.
Papanota A, Karousi P, Kontos C, Artemaki P, Liacos C, Papadimitriou M, et al.
Int J Mol Sci
. 2021 Dec;
22(23).
PMID: 34884950
Multiple myeloma (MM) is the second most common hematological malignancy, arising from terminally differentiated B cells, namely plasma cells. miRNAs are small non-coding RNAs that participate in the post-transcriptional regulation...
10.
Eid M, Karousi P, Kunovsky L, Tucek S, Brancikova D, Kala Z, et al.
Biomedicines
. 2021 Oct;
9(10).
PMID: 34680585
Pancreatic ductal adenocarcinoma (PDAC) is increasing in incidence and is still associated with a high rate of mortality. Only a minority of patients are diagnosed in the early stage. Radical...